Griffin disposed of the lion's share of his fund's stake in artificial intelligence (AI) colossus Nvidia in favor of an AI company with seemingly insurmountable competitive advantages.
Nvidia is embarking on a series of partnerships with Indian firms to deploy its AI chips and technology, deepening its push into a key growth market.
Nvidia CEO Jensen Huang admitted Wednesday that Nvidia was 100% at fault for a design flaw in the company's new Blackwell AI chips. The flaw has been fixed and the chips are now in production.
Chip behemoth Nvidia expanded tie-ups on Thursday with India's big firms, such as Reliance Industries, and launched a lightweight artificial intelligence (AI) model for the widely-used Hindi language,
South Korea's SK Hynix on Thursday posted a record quarterly profit as the Nvidia supplier saw strong sales of its advanced chips such as high bandwidth memory (HBM) ones used in generative AI chipsets.
Nvidia Corporation's uptrend, robust technical indicators, and solid fundamentals make it a buy with potential for growth and new highs. Read more on NVDA stock.
Pharmaceutical giant Novo Nordisk plans to use Denmark's first sovereign artificial intelligence supercomputer—powered by Nvidia technology—for drug discovery.
Nvidia will supply artificial intelligence processors to Indian companies such as Mukesh Ambani's Reliance Industries, the chip giant said on Thursday, as it deepens partnerships to exploit a growing market.
Artificial Intelligence is “fundamentally reshaping computing and will transform how stories are told, produced and experienced,” asserted NVIDIA founder and CEO Jensen Huang as he accepted the Charles F. Jenkins Lifetime Achievement Award via a recorded message during the 76th Engineering, Science & Technology Emmy Awards.
Nvidia (NVDA) closed at a record high Monday as Wall Street anticipates Big Tech’s earnings report in November.
Wipro's strategy leverages NVIDIA AI with ready-to-use templates based on NVIDIA NIM Agent Blueprints for faster business value in intelligent document processing, drug discovery, customer service, and claims processing.